Bangalore, Sripal <br/><br/>
β-blockers and cardiovascular events in patients with and without myocardial infarction: post hoc analysis from the CHARISMA trial.  [electronic resource] 

 -  Circulation. Cardiovascular quality and outcomes  Nov 2014 
 - 872-81 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1941-7705 
<br/><br/><label>Standard No.: </label>10.1161/CIRCOUTCOMES.114.001073  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenergic beta-Antagonists--therapeutic use<br/>Aged<br/>Female<br/>Follow-Up Studies<br/>Global Health<br/>Humans<br/>Incidence<br/>Male<br/>Middle Aged<br/>Myocardial Infarction--drug therapy<br/>Propensity Score<br/>Prospective Studies<br/>Recurrence<br/>Risk Assessment<br/>Risk Factors<br/>Survival Rate--trends<br/>Time Factors<br/>Treatment Outcome